Thrombocytopenia Treatment Market Size and forecast to 2030.

The report "Thrombocytopenia Treatment Market by Drug Class (Lysosomal Enzyme, Platelet Stimulating Agents, and Glucocorticoids), by Disease Indication (Leukemia, Hemolytic Uremic Syndrome, Immune Thrombocytopenia, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Region – Global Forecasts to 2030", is projected to reach USD 5.2 billion in 2023, having grown at a Compound Annual Growth Rate (CAGR) of 6.2% during the forecast period 2024-2030.